Mitochondrial cytopathies present a tissue specificity characterized by the fact that even if a mitochondrial DNA mutation is present in all tissues, only some will be affected and induce a pathology. Several mechanisms have been proposed to explain this phenomenon such as the appearance of a sporadic mutation in a given stem cell during embryogenesis or mitotic segregation, giving different degrees of heteroplasmy in tissues. However, these mechanisms cannot be the only ones involved in tissue specificity. In this paper, we propose an additional mechanism contributing to tissue specificity. It is based on the metabolic expression of the defect in oxidative phosphorylation (OXPHOS) complexes that can present a biochemical threshold. The value of this threshold for a given OXPHOS complex can vary according to the tissue; thus different tissues will display different sensitivities to a defect in an OXPHOS complex. To verify this hypothesis and to illustrate the pathological consequences of the variation in biochemical thresholds, we studied their values for seven OXPHOS complexes in mitochondria isolated from five different rat tissues. Two types of behavior in the threshold curves can be distinguished corresponding to two modes of OXPHOS response to a deficiency. We propose a classification of tissues according to their type of OX-PHOS response to a complex deficiency and therefore to their threshold values.Mitochondrial pathologies are a heterogeneous group of metabolic disorders characterized by abnormalities of the mitochondrial ultrastructure as well as of oxidative phosphorylation functioning (1-4). During these last years, the study of mitochondrial DNA (mtDNA) has shown, in a certain number of cases, some precise mutation sites associated with a better clinical definition of the related pathologies (5-20). In addition, it has been shown that defects in oxidative phosphorylations (OXPHOS) 1 are able to affect any tissue, thus leading to the concept of mitochondrial cytopathies (21). This underlies the problem of the variability of the phenotypic expression of an mtDNA mutation. Indeed, an OXPHOS deficit due to such a mutation will not necessarily lead to a pathology. Moreover, mitochondrial cytopathies present a tissue specificity characterized by the fact that even if a mutation is present in all tissues, only some will be affected, leading to the pathology (4,(22)(23)(24)(25).A first mechanism proposed to explain this tissue specificity is based on the random segregation of wild type and mutant mtDNAs during embryogenesis, giving different levels of heteroplasmy in tissues (4,7,26,27). In this case, only tissues with a high proportion of mutated mtDNA would be affected. However, in patients where the mitochondrial mutation is homoplasmic (25, 28) and in the case of nuclear mutations giving a uniform deficiency in all tissues, this mechanism can no longer explain the tissue specificity. For this reason, we propose another mechanism based on the threshold effect in the expression of a defect. This effect ...